ClinicalTrials.Veeva

Menu

Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

CTLA4 Haploinsufficiency

Study type

Observational

Funder types

Other

Identifiers

NCT05040256
RECHMPL21_0290

Details and patient eligibility

About

CTLA4 and LRBA deficiencies are rare genetic disorders, recently described, and associated with multiple clinical features. It ranges from recurrent infections, auto-immunity, and organ infiltration with lymphocytes. Neurologic syndroms are described in up to 30% of patients, yet they are poorly defined to date. Early recognition of a specific pattern can be important, given that there is a targeted therapy in this situation.

Enrollment

20 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with CTLA4 or LRBA mutation

Exclusion criteria

  • Age < 12 years

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems